How to buy Personalis stock | $19.94

Personalis Inc is a diagnostics & research business based in the US. Personalis shares (PSNL) are listed on the NASDAQ and all prices are listed in US Dollars. Personalis employs 234 staff and has a trailing 12-month revenue of around 0.00.

Personalis stock price (NASDAQ: PSNL)

Use our graph to track the performance of PSNL stocks over time.

Personalis shares at a glance

• Key figures

Information last updated 2021-10-16.

Latest market close	$19.94
52-week range	$16.54 - $53.46
50-day moving average	$20.39
200-day moving average	$21.68
Wall St. target price	$32.14
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.25

Buy Personalis shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Personalis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Personalis price performance over time

Historical closes compared with the close of $19.94 from 2021-10-15

1 week (2021-10-08)	6.86%
1 month (2021-09-17)	-10.90%
3 months (2021-07-16)	-6.78%
6 months (2021-04-16)	-10.14%

1 year (2020-10-16)	-25.12%
2 years (2019-10-17)	63.04%
3 years (2018-10-13)	N/A
5 years (2016-10-13)	N/A

Personalis financials

Revenue TTM	$82.5 million
Gross profit TTM	$20.1 million
Return on assets TTM	-11.93%
Return on equity TTM	-23.27%
Profit margin	-60.87%
Book value	$7.66
Market capitalisation	$885.6 million

TTM: trailing 12 months

Shorting Personalis shares

There are currently 1.8 million Personalis shares held short by investors – that's known as Personalis's "short interest". This figure is 4.4% down from 1.9 million last month.

There are a few different ways that this level of interest in shorting Personalis shares can be evaluated.

Personalis's "short interest ratio" (SIR)

Personalis's "short interest ratio" (SIR) is the quantity of Personalis shares currently shorted divided by the average quantity of Personalis shares traded daily (recently around 388587.65957447). Personalis's SIR currently stands at 4.7. In other words for every 100,000 Personalis shares traded daily on the market, roughly 4700 shares are currently held short.

However Personalis's short interest can also be evaluated against the total number of Personalis shares, or, against the total number of tradable Personalis shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Personalis's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Personalis shares in existence, roughly 40 shares are currently held short) or 0.0512% of the tradable shares (for every 100,000 tradable Personalis shares, roughly 51 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Personalis.

Find out more about how you can short Personalis stock.

Personalis share dividends

We're not expecting Personalis to pay a dividend over the next 12 months.

Personalis share price volatility

Over the last 12 months, Personalis's shares have ranged in value from as little as $16.54 up to $53.46. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Personalis's is 1.4966. This would suggest that Personalis's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Personalis overview

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.

Frequently asked questions

What percentage of Personalis is owned by insiders or institutions?
Currently 2.193% of Personalis shares are held by insiders and 88.14% by institutions. How many people work for Personalis?
Latest data suggests 234 work at Personalis. When does the fiscal year end for Personalis?
Personalis's fiscal year ends in December. Where is Personalis based?
Personalis's address is: 1330 O?Brien Drive, Menlo Park, CA, United States, 94025 What is Personalis's ISIN number?
Personalis's international securities identification number is: US71535D1063 What is Personalis's CUSIP number?
Personalis's Committee on Uniform Securities Identification Procedures number is: 71535D106